210 related articles for article (PubMed ID: 35588085)
1. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
Huang SH; Jacinto JCK; O'Sullivan B; Su J; Kim J; Ringash J; Spreafico A; Yu E; Perez-Ordonez B; Weinreb I; Cho J; Hope AJ; Bratman SV; Giuliani ME; Hosni A; Hahn E; Goldstein DP; Tong L; Eng L; Xu W; Waldron JN
Cancer; 2022 Aug; 128(15):2908-2921. PubMed ID: 35588085
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
Wu SS; Chen B; Fleming CW; Shah AA; Griffith CC; Domb C; Reddy CA; Campbell SR; Woody NM; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman L; Geiger JL; Koyfman SA; Ku JA
Head Neck; 2022 Apr; 44(4):851-861. PubMed ID: 35040516
[TBL] [Abstract][Full Text] [Related]
3. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
Punwaney R; Brandwein MS; Zhang DY; Urken ML; Cheng R; Park CS; Li HB; Li X
Head Neck; 1999 Jan; 21(1):21-9. PubMed ID: 9890347
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
Verma N; Patel S; Osborn V; McBride S; Riaz N; Lee A; Katabi N; Sherman E; Lee NY; Tsai CJ
Head Neck; 2020 Sep; 42(9):2364-2374. PubMed ID: 32415906
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
[TBL] [Abstract][Full Text] [Related]
7. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.
Stenmark MH; McHugh JB; Schipper M; Walline HM; Komarck C; Feng FY; Worden FP; Wolf GT; Chepeha DB; Prince ME; Bradford CR; Mukherji SK; Eisbruch A; Carey TE
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):580-8. PubMed ID: 24521676
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
Dogan S; Hedberg ML; Ferris RL; Rath TJ; Assaad AM; Chiosea SI
Head Neck; 2014 Apr; 36(4):511-6. PubMed ID: 23780921
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Liu MZ; Fang SG; Huang W; Wang HY; Tian YM; Huang RD; Sun Z; Zhao C; Lu TX; Huang Y; Han F
Cancer Med; 2019 Aug; 8(10):4633-4643. PubMed ID: 31268626
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
[TBL] [Abstract][Full Text] [Related]
12. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
Maxwell JH; Kumar B; Feng FY; McHugh JB; Cordell KG; Eisbruch A; Worden FP; Wolf GT; Prince ME; Moyer JS; Teknos TN; Chepeha DB; Stoerker J; Walline H; Carey TE; Bradford CR
Head Neck; 2010 May; 32(5):562-7. PubMed ID: 19757421
[TBL] [Abstract][Full Text] [Related]
13. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
[TBL] [Abstract][Full Text] [Related]
14. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
16. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
18. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
